Literature DB >> 25469732

B-type natriuretic peptide vs. cardiac risk scores for prediction of outcome following major orthopedic surgery.

Spyridon Katsanos1, Dimitrios Babalis, Nikolaos Kafkas, Andreas Mavrogenis, Darryl Leong, John Parissis, Christos Varounis, Konstantinos Makris, Aafke van der Heijden, Maria Anastasiou-Nana, Gerasimos Filippatos.   

Abstract

AIMS: The clinical role of B-type natriuretic peptide (BNP) in preoperative evaluation is not clear. We designed a prospective study to investigate the predictive value of BNP in comparison with established clinical risk scores for the outcome of major orthopedic surgery.
METHODS: Overall 242 elderly patients [80 (74-85) years] undergoing orthopedic surgery were included. Inhospital cardiovascular events and 1-year mortality were the main endpoints.
RESULTS: In total 20 (8.3%) patients had major cardiovascular events (MACE) and 41 (21.1%) died in 1 year. Logistic regression analysis for prediction of cardiac events and 1-year mortality, respectively, revealed a significant prognostic value for the BNP (P < 0.001 and P = 0.041), Goldman (P = 0.013 and P = 0.003), Lee (P = 0.022 and P = 0.200), Detsky (P < 0.001 and P < 0.001), and functional capacity indices (P = 0.034 and P = 0.001). BNP cutoff 149 ng/ml improved discrimination of all scores to predict MACE, and BNP cutoff 89 ng/ml improved discrimination of all scores to predict 1-year mortality (Net Reclassification Improvement, P values < 0.05 in all cases). Age [hazard ratio (HR): 1.100, 95% confidence interval (CI): 1.039-1.166, P = 0.001] and BNP (HR: 1.002, 95% CI: 1.000-1.003, P = 0.041) were independent associates of 1-year mortality.
CONCLUSION: Preoperative levels of BNP compare favorably with the Goldman, Lee, Detsky, and functional capacity indices for prognosis of orthopedic surgery. Implementation of natriuretic peptides in cardiac risk scores is promising.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25469732     DOI: 10.2459/JCM.0000000000000210

Source DB:  PubMed          Journal:  J Cardiovasc Med (Hagerstown)        ISSN: 1558-2027            Impact factor:   2.160


  3 in total

1. 

Authors:  Berrin Günaydın; Ömer Kurtipek
Journal:  Turk J Anaesthesiol Reanim       Date:  2018-06-01

2.  Risk factors for adverse cardiac events in hip fracture patients: an analysis of NSQIP data.

Authors:  Vasanth Sathiyakumar; Frank R Avilucea; Paul S Whiting; A Alex Jahangir; Hassan R Mir; William T Obremskey; Manish K Sethi
Journal:  Int Orthop       Date:  2015-07-21       Impact factor: 3.075

Review 3.  The comparative and added prognostic value of biomarkers to the Revised Cardiac Risk Index for preoperative prediction of major adverse cardiac events and all-cause mortality in patients who undergo noncardiac surgery.

Authors:  Lisette M Vernooij; Wilton A van Klei; Karel Gm Moons; Toshihiko Takada; Judith van Waes; Johanna Aag Damen
Journal:  Cochrane Database Syst Rev       Date:  2021-12-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.